They can cause strong physical and emotional symptoms
[7] PharmaCotherapia d.o.o., Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source., clinicaltrials.gov, Clinical trial registration NCT02637284, Dec
At this time it is unclear what the cause is of this shortage, however with the dramatic increase in the use of cobalt for electric vehicle batteries, with 40 pounds of cobalt required for each battery, this may be a potential diversion of the cobalt away from the manufacture of cobalamin (B12) for injectable vitamin
Starting at lower doses allows assessment of individual tolerance and response before potentially increasing the dose